Clofazimine- and Rifapentine-Containing Treatment Shortening Regimens in Drug-Susceptible Tuberculosis: The CLO-FAST Study
Clinical trial NCT04311502 · TERMINATED
Trial details
- NCT number
- NCT04311502
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-05
- Primary completion
- 2024-06-24
- Enrollment
- 104
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.